BioTime Inc. (BTIM/BTIM.OB) Wrap Up:

BioTime, Inc., a biomedical company, engages in the research and development of synthetic plasma expanders, blood volume substitute solutions, and organ preservation solutions for use in surgery, trauma care, organ transplant procedures, and other areas of medicine. Its lead product, Hextend, is a hetastarch-based synthetic blood plasma volume expander designed to treat hypovolemia in surgery for patients with blood loss. The company is also developing PentaLyte, a pentastarch-based synthetic plasma expander for the treatment of hypovolemia in cardiac surgery; HetaCool, a modified formulation of Hextend, which is designed for use at low temperatures; and other synthetic plasma expander solut...